Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-02-22
1998-02-17
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514307, 514310, 514313, 514415, 514416, 546141, 546143, 546146, 546149, 546151, 546153, 546159, 546156, 546174, 548483, 548484, 548492, 548494, 548495, 548503, 548509, 548510, 548514, 540523, 540463, C07D21722, C07D21512, A61K 3155, A61K 3147
Patent
active
057191441
ABSTRACT:
Fibrinogen receptor antagonists having the formula ##STR1## where L is L is (CH.sub.2).sub.p, where p is 1 or 2; and Z is --CR.sup.1 .dbd.CR.sup.2 --; which are useful for inhibiting platelet aggregation for example ##STR2##
REFERENCES:
patent: 3322631 (1967-05-01), Sprague et al.
patent: 4010274 (1977-03-01), Giraldi et al.
patent: 4122255 (1978-10-01), Krapcho
patent: 4243807 (1981-01-01), Friebe et al.
patent: 4313947 (1982-02-01), Nakagawa et al.
patent: 4622331 (1986-11-01), Jozic
patent: 5030654 (1991-07-01), Barnish et al.
patent: 5227490 (1993-07-01), Hartman et al.
patent: 5260316 (1993-11-01), Van Duzer et al.
patent: 5264420 (1993-11-01), Duggan et al.
patent: 5272158 (1993-12-01), Hartman et al.
patent: 5281585 (1994-01-01), Duggan et al.
patent: 5292756 (1994-03-01), Duggan et al.
patent: 5294616 (1994-03-01), Duggan et al.
patent: 5321034 (1994-06-01), Duggan et al.
patent: 5334596 (1994-08-01), Hartman et al.
patent: 5358956 (1994-10-01), Hartman et al.
Halczenko Wasyl
Hartman George D.
Hutchinson John H.
Berch Mark L.
Kifle Bruck
Merck & Co. , Inc.
Parr Richard S.
Winokur Melvin
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784133